Ropes & Gray Advised Bain Capital in Investment in Kailera Therapeutics’ $600 Million Series B Financing
Global Leading Law Firm Ropes & Gray advised long term client Bain Capital as it led Kailera Therapeutics’ $600 million
Ropes & Gray Advised Bain Capital in Investment in Kailera Therapeutics’ $600 Million Series B Financing
Global Leading Law Firm Ropes & Gray advised long term client Bain Capital as it led Kailera Therapeutics’ $600 million Series B financing. Kailera Therapeutics is a clinical-stage biopharmaceutical company focused on advancing a differentiated, late-stage portfolio of next-generation therapies for the treatment of obesity.
The financing, which was announced on October 14, will be fully funded at closing and will support the advancement of Kailera’s obesity portfolio, including a global Phase 3 clinical program of Kailera’s lead candidate KAI-9531, an injectable dual GLP-1/GIP receptor agonist.
The Ropes & Gray team was led by venture capital and emerging companies Rajarshi Banerjee (Partner), Melissa S. Rones (Partner) Bryan Hunkele (Partner), Deidre J. Johnson (Partner), Renata J. Ferrari (Partner), Megan Bisk (Partner) , Gregory H. Levine (Partner), Michael R. Littenberg (Partner), Edward R. McNicholas (Partner), and Derek Mubiru (Associate), Ryan Haynes (Associate) , Michael E. Connolly and (Counsel), Ryan Murphey (Counsel), and Derek A. Yee (Counsel).
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922